immunity News and Research

RSS

New strategies for dealing with future pandemics

In a recent study, researchers explore strategies for managing pandemics as well as model potentially optimal solutions.

18 Nov 2021

What is the public perception surrounding COVID immunity certificates?

Researchers investigate views on immunity certificates and how they interact with other opinions on the pandemic.

18 Nov 2021

NIH study finds naturally acquired immunity is weak against SARS-CoV-2 variants

Immunity acquired after recovering from SARS-CoV-2 infection is not sufficient in protecting against reinfection from variants.

18 Nov 2021

SARS-CoV-2 infection and reinfection in farmed mink

A new study finds that farmed mink acquire SARS-CoV-2 infection, freely transmit it among themselves, and were reinfected, despite being seropositive.

18 Nov 2021

Short-term severe calorie restriction safe, feasible, and well tolerated by cancer patients

A diet involving short-term, severe calorie restriction was safe, feasible, and resulted in a decrease of blood glucose and growth factor concentration, reduction in peripheral blood immunosuppressive cells, and enhanced intratumor T-cell infiltration in cancer patients receiving standard-of-care therapy, according to the results of a clinical trial.

18 Nov 2021

Real-world effectiveness and safety of COVID-19 vaccines

A new study published in Infectious Diseases of Poverty aimed to systematically evaluate the effectiveness and safety of the COVID-19 vaccines in the real world as well as establish a reliable evidence-based basis to determine the actual protective effect of the COVID-19 vaccines, especially considering the new waves of infection brought about by the variants.

18 Nov 2021

Evidence of significantly greater protection against COVID from BNT162b2 boosters

In a new study, researchers from several British institutes estimated the effectiveness of booster vaccination against symptomatic COVID-19 in adults aged 50 years and older.

18 Nov 2021

Vaccines and boosters remain strong against current SARS-CoV-2 variants

In a recent study published in the Lancet Microbe journal, Australian researchers studied whether in-vitro neutralization titers could predict vaccine protection from SARS-CoV-2 variants.

17 Nov 2021

Study reveals complex interplay between diet, gut microbiota, and immune function

The cliché "you are what you eat" has been used for hundreds of years to illustrate the link between diet and health. Now, an international team of researchers has found the molecular proof of this concept, demonstrating how diet ultimately affects immunity through the gut microbiome.

17 Nov 2021

Long-term Pfizer vaccine-elicited SARS-CoV-2 antibody profile in breast milk

A new study indicates that the Pfizer vaccine induces antibodies in the breast milk against SARS-CoV-2.

17 Nov 2021

P681H mutation helps SARS-CoV-2 VOCs replicate faster and resist innate immunity

In the current study, researchers compare the IFITM sensitivities of major SARS-CoV-2 VOCs.

17 Nov 2021

SARS-CoV-2 reinfection associated with housing instability

Researchers examine the impact of demographic factors and antibody responses following SARS-CoV-2 reinfection.

17 Nov 2021

Excess mortality reveals infection speed in COVID-19 is low with seasonal infection patterns and escape variants

Researchers from the University of Wurzburg in Germany have been attempting to create a new method for determining the R0 using excess mortality data.

17 Nov 2021

Effect of contact networks on SARS-CoV-2 transmission and control

A study demonstrated that the social contacts created in different activity settings affect interventions needed to control outbreaks.

17 Nov 2021

Nationwide Swedish study strengthens evidence for a third booster COVID vaccine dose

A nationwide study from Sweden investigates the effectiveness of COVID-19 vaccination against the risk of symptomatic infection, hospitalization, and death up to 9 months post-vaccination. This study is published on the Preprints with The Lancet website while awaiting peer review.

17 Nov 2021

How effective is the COMIRNATY BNT162b2 vaccine against the SARS-CoV-2 Lambda variant?

Now, researchers from Public Health Services Israel have been investigating a new variant called Lambda to see if it qualifies as a variant of concern. Their research is published in the journal Eurosurveillance.

16 Nov 2021

Study: Covid-19 vaccine-elicited immune cells persist six months after vaccination

A recent study by Johns Hopkins Medicine researchers provides evidence that CD4+ T lymphocytes — immune system cells also known as helper T cells — produced by people who received either of the two available messenger RNA (mRNA) vaccines for COVID-19 persist six months after vaccination at only slightly reduced levels from two weeks after vaccination and are at significantly higher levels than for those who are unvaccinated.

16 Nov 2021

immunity News and Research

New strategies for dealing with future pandemics

What is the public perception surrounding COVID immunity certificates?

NIH study finds naturally acquired immunity is weak against SARS-CoV-2 variants

SARS-CoV-2 infection and reinfection in farmed mink

Short-term severe calorie restriction safe, feasible, and well tolerated by cancer patients

Real-world effectiveness and safety of COVID-19 vaccines

Evidence of significantly greater protection against COVID from BNT162b2 boosters

Vaccines and boosters remain strong against current SARS-CoV-2 variants

Study reveals complex interplay between diet, gut microbiota, and immune function

Long-term Pfizer vaccine-elicited SARS-CoV-2 antibody profile in breast milk

P681H mutation helps SARS-CoV-2 VOCs replicate faster and resist innate immunity

SARS-CoV-2 reinfection associated with housing instability

Excess mortality reveals infection speed in COVID-19 is low with seasonal infection patterns and escape variants

Effect of contact networks on SARS-CoV-2 transmission and control

Nationwide Swedish study strengthens evidence for a third booster COVID vaccine dose

How effective is the COMIRNATY BNT162b2 vaccine against the SARS-CoV-2 Lambda variant?

Study: Covid-19 vaccine-elicited immune cells persist six months after vaccination

Two genetic risk variants in Black individuals may exacerbate sepsis and COVID-19 severity

Elderly residents of long-term care facilities benefit from booster vaccines against SARS-CoV-2

A therapeutic interfering particle for SARS-CoV-2

Exploring Strategies for Targeting Kinases in Innate Immunity eBook

Decoding Cannabis: Differentiating Hemp and Marijuana

Deciphering the Microbiome with The Microsetta Initiative

Leveraging the power of automation to boost research

Latest News